Closing Figures: Rockwell Medical Inc (RMTI)’s Negative Finish at 2.83, Down -39.14

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $4.65 in the prior trading day, Rockwell Medical Inc (NASDAQ: RMTI) closed at $2.83, down -39.14%. In other words, the price has decreased by -$39.14 from its previous closing price. On the day, 6.44 million shares were traded. RMTI stock price reached its highest trading level at $3.62 during the session, while it also had its lowest trading level at $2.81.

Ratios:

Our goal is to gain a better understanding of RMTI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.60 and its Current Ratio is at 2.00. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.40.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Jaffray on June 24, 2019, initiated with a Overweight rating and assigned the stock a target price of $10.

On May 13, 2019, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 01 ’24 when Chole Timothy sold 1,001 shares for $3.69 per share. The transaction valued at 3,689 led to the insider holds 55,171 shares of the business.

Strobeck Mark sold 2,163 shares of RMTI for $7,971 on Oct 01 ’24. The President and CEO now owns 147,201 shares after completing the transaction at $3.69 per share. On Oct 01 ’24, another insider, Strobeck Mark, who serves as the Officer of the company, bought 2,163 shares for $3.65 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMTI now has a Market Capitalization of 87815464 and an Enterprise Value of 90329520. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.89 while its Price-to-Book (P/B) ratio in mrq is 3.14. Its current Enterprise Value per Revenue stands at 0.957 whereas that against EBITDA is -102.067.

Stock Price History:

Over the past 52 weeks, RMTI has reached a high of $5.15, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is -23.87%, while the 200-Day Moving Average is calculated to be 25.11%.

Shares Statistics:

The stock has traded on average 604.47K shares per day over the past 3-months and 1295210 shares per day over the last 10 days, according to various share statistics. A total of 29.13M shares are outstanding, with a floating share count of 27.16M. Insiders hold about 12.48% of the company’s shares, while institutions hold 20.70% stake in the company. Shares short for RMTI as of 1728950400 were 823372 with a Short Ratio of 1.48, compared to 1726185600 on 397531. Therefore, it implies a Short% of Shares Outstanding of 823372 and a Short% of Float of 2.6700001.

Most Popular